Literature DB >> 27432088

Increasing Number of People with Diabetes in Japan: Is This Trend Real?

Atsushi Goto1, Mitsuhiko Noda, Manami Inoue, Maki Goto, Hadrien Charvat.   

Abstract

Diabetes mellitus, especially type 2 diabetes, has been a major concern among health issues for Japanese policy requiring serious address. In this regard, the increasing number of people with diabetes in Japan over the past few decades has been regarded as a fundamental and evident problem. We herein clarify that the crude diabetes prevalence is likely to have increased mainly as a result of changes in the population distribution, namely, aging of the general population in Japan. We also predict the future trend for the number of people with diabetes according to available concrete evidence in this review.

Entities:  

Mesh:

Year:  2016        PMID: 27432088     DOI: 10.2169/internalmedicine.55.6475

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  16 in total

1.  High-frequency HbA1c testing among older patients with diabetes in Japan: a longitudinal analysis using medical claims data.

Authors:  Ning Liu; Yoshihisa Fujino; Kenji Fujimoto; Makoto Ohtani; Hanaka Imamura; Shinya Matsuda
Journal:  Diabetol Int       Date:  2022-05-09

2.  Safety and Pharmacokinetics of DS-8500a, a Novel GPR119 Agonist, After Multiple Oral Doses in Healthy Japanese Males.

Authors:  Manabu Kato; Hidetoshi Furuie; Emi Kamiyama; Kazuhito Shiosakai; Kazutaka Yoshihara; Takashi Taguchi
Journal:  Clin Drug Investig       Date:  2018-06       Impact factor: 2.859

3.  Japanese translation and linguistic validation of the Prosthetic Limb Users Survey of Mobility (PLUS-M).

Authors:  Geoffrey S Balkman; Soshi Samejima; Kazuki Fujimoto; Brian J Hafner
Journal:  Prosthet Orthot Int       Date:  2022-02-01       Impact factor: 1.672

4.  Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis.

Authors:  Hideaki Jinnouchi; Makoto Imori; Hiroshi Nishiyama; Takeshi Imaoka
Journal:  Diabetes Ther       Date:  2020-07-29       Impact factor: 2.945

5.  Cumulative Risk of Type 2 Diabetes in a Working Population: The Japan Epidemiology Collaboration on Occupational Health Study.

Authors:  Huanhuan Hu; Tohru Nakagawa; Hiroko Okazaki; Chihiro Nishiura; Teppei Imai; Toshiaki Miyamoto; Naoko Sasaki; Makoto Yamamoto; Taizo Murakami; Takeshi Kochi; Masafumi Eguchi; Kentaro Tomita; Satsue Nagahama; Keisuke Kuwahara; Isamu Kabe; Tetsuya Mizoue; Seitaro Dohi
Journal:  J Epidemiol       Date:  2018-05-04       Impact factor: 3.211

6.  Visceral Fat Accumulation Is Associated with Asthma in Patients with Type 2 Diabetes.

Authors:  Daisuke Murakami; Futoshi Anan; Takayuki Masaki; Yoshikazu Umeno; Takehiko Shigenaga; Nobuoki Eshima; Takashi Nakagawa
Journal:  J Diabetes Res       Date:  2019-05-02       Impact factor: 4.011

7.  Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes.

Authors:  Kentaro Okazaki; Tomotaka Shingaki; Zhihong Cai; Magaly Perez-Nieves; Lawrence Fisher
Journal:  Diabetes Ther       Date:  2019-07-08       Impact factor: 2.945

8.  An evaluation of the impact of aggressive hypertension, diabetes and smoking cessation management on CVD outcomes at the population level: a dynamic simulation analysis.

Authors:  John Pastor Ansah; Ryan Leung Hoe Inn; Salman Ahmad
Journal:  BMC Public Health       Date:  2019-08-14       Impact factor: 3.295

9.  Retrospective study of factors associated with progression and remission/regression of diabetic kidney disease-hypomagnesemia was associated with progression and elevated serum alanine aminotransferase levels were associated with remission or regression.

Authors:  Tatsuo Yanagawa; Keiko Koyano; Koichiro Azuma
Journal:  Diabetol Int       Date:  2021-01-02

10.  Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study.

Authors:  Kohei Kaku; Shingo Kuroda; Kazuyuki Ishida; Yuusuke Umeda
Journal:  Diabetes Obes Metab       Date:  2018-07-02       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.